Neurocrine Biosciences
NBIX
#1689
Rank
$12.90 B
Marketcap
$128.63
Share price
-1.13%
Change (1 day)
10.78%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of December 2025 : $3.25 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company has $3.25 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$$3.25 B25.62%
2024-12-31$$2.58 B16.03%
2023-12-31$$2.23 B30.69%
2022-12-31$$1.70 B24.29%
2021-12-31$$1.37 B22%
2020-12-31$$1.12 B76.83%
2019-12-31$$0.63 B32.48%
2018-12-31$$0.48 B29.19%
2017-12-31$$0.37 B18.19%
2016-12-31$$0.31 B-25.82%
2015-12-31$$0.42 B103.38%
2014-12-31$$0.20 B73.32%
2013-12-31$$0.12 B-22%
2012-12-31$$0.15 B156.94%
2011-12-31$$60.08 M210.58%
2010-12-31$$19.34 M389.25%
2009-12-31$$3.95 M-89.25%
2008-12-31$$36.77 M-69.02%
2007-12-31$$0.11 B-62.28%
2006-12-31$$0.31 B-19.33%
2005-12-31$$0.39 B-0.95%
2004-12-31$$0.39 B0.69%
2003-12-31$$0.39 B74.41%
2002-12-31$$0.22 B-27.75%
2001-12-31$$0.31 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$93.09 B 2,761.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-$2.6 Billion-179.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$26.53 B 715.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$2.08 B-35.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$36.4 Million-101.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.50 B-84.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$0.39 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
$9.71 B 198.64%๐Ÿ‡ฌ๐Ÿ‡ง UK